Biotech Outsourcing: Trends, CDMO Growth, And Expansion
Outsourcing has become an important part of the biotech business because many contract manufacturing organizations (CMOs) are the only ones that can make the huge amounts of medicines and treatments that are needed. Some other reasons to outsource are to keep costs down and limit internal staff and resources, to get the word out about […]
Advancing Continuous Bioprocessing For Enhanced Productivity
The biopharmaceutical sector is now going through a significant transition toward continuous bioprocessing which is currently taking place. In contrast to the conventional batch processing method, which is characterized by the presence of distinct phases and interim holding tanks, the consistent bioprocessing method functions without any interruptions. Within the confines of a single interconnected system, […]
Generative AI In Pharma: Major Opportunities And Hurdles
Among the pharmaceutical DX-digital transformation professionals, 67% responded that they were not ready when asked about how ready the life sciences sector is to effectively go ahead and leverage generative AI in terms of infrastructure, regulatory considerations, and expertise. This is according to a new report published by Axendia Market Research. A total of 43 […]
Global Biopharma Market To Hit $566B By 2032 Amid Challenges
The value of the global biopharmaceutical industry is expected to rise significantly, from $263 billion in 2022 to $566 billion by 2032, representing a compound annual growth rate of about 8% from 2023 to 2032. This growth is mostly being driven by the rising need for novel therapies, chronic illnesses, and the increasing incidence of […]
CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. In Switzerland, CordenPharma will invest >€500m to construct a greenfield site for small to large-scale peptide development and manufacturing located within the Basel region in […]
Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis
Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy, have a profound impact on patients and their families. Developing effective treatments for these conditions is faster when we have access to translational models that help identify promising drug candidates for clinical trials. This article provides […]
Innovative Stem Cell Therapies: Transforming Regenerative Medicine and Patient Care
In recent years, stem cell therapy has emerged as a groundbreaking approach in regenerative medicine, offering patients innovative ways to support healing and recovery. A fundamental shift is occurring in healthcare—one that moves away from traditional, one-size-fits-all pharmaceutical solutions and toward personalized, biologically driven approaches. Physicians are now harnessing patients’ own stem cells to promote […]
Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn
The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over 2,500 people worldwide and has locations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Solventum’s Purification & Filtration division is expected to earn almost $1 […]
LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab
LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites. Celonic Group will produce catumaxomab for commercial use. Catumaxomab will be manufactured at Celonic’s advanced GMP facility in Heidelberg, Germany. LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it […]
Alexion and DHL Partner for 100% Sustainable Aviation Fuel
Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL Express to achieve Ireland’s first 100% switch to Sustainable Aviation Fuel (SAF) for international air delivery of medicines. This move will reduce greenhouse gas (GHG) emissions by over 80% compared to traditional aviation fuel, covering shipments to 19 European countries. SAF, provided through DHL’s GoGreen Plus […]
